Publications by authors named "Maria-Concetta Petti"

Claim this Profile
L
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients.
Frédéric Baron, Fabio Efficace, Laura Cannella, Roel Willemze, Marco Vignetti, Maria Concetta Petti

Haematologica· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flow cytometry remission by Ig light chains ratio is a powerful marker of outcome in multiple myeloma after tandem autologous transplant: a real-life study.
Iole Cordone, Francesco Marchesi, Serena Masi, Valentina Summa, Francesco Pisani, Maria Concetta Petti

J Exp Clin Cancer Res· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts.
Alessandra Picardi, Andrea Mengarelli, Mirella Marino, Enzo Gallo, Maria Benevolo, Maria Concetta Petti

J Exp Clin Cancer Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age.
Paola Finsinger, Massimo Breccia, Clara Minotti, Ida Carmosino, Corrado Girmenia, Maria Concetta Petti

Ann Hematol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-recognition of aspergillus galactomannan caused by Listeria monocytogenes infection.
Maria Concetta Petti, Grazia Prignano, Andrea Mengarelli, Antonio Spadea, Laura Cilli

Diagn Microbiol Infect Dis· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy.
Francesco Pisani, Maria Teresa Petrucci, Diana Giannarelli, Velia Bongarzoni, Marco Montanaro, Maria Concetta Petti

J Exp Clin Cancer Res· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: a study from the Rome Transplant Network.
Francesco Marchesi, Federica Giannotti, Giuseppe Avvisati, Maria Concetta Petti, Fulvia Pimpinelli

Am J Hematol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols.
Massimo Breccia, Luca Mazzarella, Vincenzo Bagnardi, Davide Disalvatore, Giuseppina Loglisci, Maria Concetta Petti

Blood· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term seventh molecular remission in acute promyelocytic leukaemia.
Laura Cicconi, Atelda Romano, Safaa M Ramadan, Mariadomenica Divona, Maria Concetta Petti

Ann Hematol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long-term results and prognostic factors.
Roberto Latagliata, Massimo Breccia, Paola Fazi, Marco Vignetti, Francesco Di Raimondo, Maria Concetta Petti

Br J Haematol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance.
Giuseppe Avvisati, Francesco Lo-Coco, Francesca Paola Paoloni, Maria Concetta Petti, Daniela Diverio

Blood· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FCR (Fludarabine, Cyclophosphamide, Rituximab) regimen followed by 90Yttrium ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma: a report of 9 cases.
Francesco Pisani, Carlo Ludovico Maini, Rosa Sciuto, Laura Dessanti, Mariella D'Andrea, Maria Concetta Petti

J Exp Clin Cancer Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization.
Azzurra Romeo, Anna Chierichini, Alessandra Spagnoli, Mariangela Vittori, Michele Vacca, Maria Concetta Petti

Transfusion· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients.
Pier Luigi Zinzani, Giuseppe Rossi, Silvia Franceschetti, Barbara Botto, Alice Di Rocco, Maria Concetta Petti

Clin Cancer Res· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decisional flow with a scoring system to start platelet-lowering treatment in patients with essential thrombocythemia: long-term results.
Roberto Latagliata, Angela Rago, Antonio Spadea, Cristina Santoro, Ida Carmosino, Maria Concetta Petti

Int J Hematol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma.
Enrico Derenzini, Vittorio Stefoni, Cinzia Pellegrini, Maria Paola Fina, Alessandro Broccoli, Maria Concetta Petti

Leuk Lymphoma· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10.
Franco Mandelli, Marco Vignetti, Stefan Suciu, Roberto Stasi, Maria-Concetta Petti

J Clin Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes.
Maria Teresa Voso, Valeria Santini, Carlo Finelli, Pellegrino Musto, Enrico Pogliani, Maria Concetta Petti

Clin Cancer Res· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of serum IGF-I levels in patients affected with Monoclonal Gammopathies of undetermined significance or Multiple Myeloma. Comparison with bFGF, VEGF and K-ras gene mutation.
Claudia Greco, Gaetano Vitelli, Giuseppe Vercillo, Rosa Vona, Diana Giannarelli, Maria Concetta Petti

J Exp Clin Cancer Res· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin.
Massimo Breccia, Roberto Latagliata, Ida Carmosino, Laura Cannella, Daniela Diverio, Maria Concetta Petti

Haematologica· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follicular dendritic cell sarcoma of the neck: report of a case treated by surgical excision and COP plus (PEG)-liposomal doxorubicin.
Francesco Pisani, Mirella Marino, Steno Sentinelli, Maria Concetta Petti

J Exp Clin Cancer Res· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late relapses in acute promyelocytic leukaemia.
Roberto Latagliata, Ida Carmosino, Massimo Breccia, Antonio Minni, Anna Testi, Maria Concetta Petti

Acta Haematol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia.
Giuseppe Cimino, Francesco Lo-Coco, Susanna Fenu, Lorena Travaglini, Erica Finolezzi, Maria Concetta Petti

Cancer Res· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arsenic trioxide in the treatment of advanced acute promyelocytic leukemia.
Ida Carmosino, Roberto Latagliata, Giuseppe Avvisati, Massimo Breccia, Erica Finolezzi, Maria Concetta Petti

Haematologica· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia secondary to a myelodysplastic syndrome with t(3;3) (q21;q26) in an HIV patient treated with chemotherapy and highly active antiretroviral therapy.
Massimo Breccia, Giuseppe Gentile, Pietro Martino, Maria Concetta Petti, Eleonora Russo

Acta Haematol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis